Anti-HMGCR and anti-DFS70 antibodies immunofluorescence patterns

Autoimmunity Reviews

Volumn 16, Issue 3, 2017, Pages 321-322

  Palterer, Boaz ^a   Cammelli, Daniele ^b   Vitiello, Gianfranco ^a   Giudizi, Maria Grazia ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

DFS70; HMGCR; Immunofluorescence; Myositis; Statins

Indexed keywords

ANTIBODY; DFS70 ANTIBODY; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; UNCLASSIFIED DRUG; HMGCR PROTEIN, HUMAN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; ASTHENIA; AUTOIMMUNE DISEASE; AWARENESS; CASE REPORT; COHORT ANALYSIS; CONNECTIVE TISSUE DISEASE; ELECTROMYOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FALSE POSITIVE RESULT; FEMALE; FOLLOW UP; HEP-2 CELL LINE; HUMAN; IMMUNOADSORPTION; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; INCLUSION BODY MYOSITIS; LABORATORY TEST; LETTER; MIDDLE AGED; MUSCLE BIOPSY; REINFORCEMENT; FLUORESCENT ANTIBODY TECHNIQUE; MUSCLE DISEASE;

AUTOIMMUNE DISEASES; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; HYDROXYMETHYLGLUTARYL COA REDUCTASES; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MUSCULAR DISEASES;

EID: 85009382803     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2017.01.002     Document Type: Letter

References (6)

1. [1] Alvarado-Cardenas, M., Marin-Sánchez, A., Martínez, M.A., Martínez-Martínez, L., Pinal-Fernandez, I., Labrador-Horrillo, M., et al. Statin-associated autoimmune myopathy: a distinct new IFL pattern can increase the rate of HMGCR antibody detection by clinical laboratories. Autoimmun Rev, 1–6, 2016, 10.1016/j.autrev.2016.09.005.
2. [2] Musset, L., Miyara, M., Benveniste, O., Charuel, J.-L., Shikhman, A., Boyer, O., et al. Analysis of autoantibodies to 3-hydroxy-3-methylglutaryl-coenzyme a reductase using different technologies. J Immunol Res 2014 (2014), 1–8, 10.1155/2014/405956.
3. [3] Drouot, L., Allenbach, Y., Jouen, F., Charuel, J.-L., Martinet, J., Meyer, A., et al. Exploring necrotizing autoimmune myopathies with a novel immunoassay for anti-3-hydroxy-3-methyl-glutaryl-CoA reductase autoantibodies. Arthritis Res Ther, 16, 2014, R39, 10.1186/ar4468.
4. [4] Ochs, R.L., Mahler, M., Basu, A., Rios-Colon, L., Sanchez, T.W., Andrade, L.E., et al. The significance of autoantibodies to DFS70/LEDGFp75 in health and disease: integrating basic science with clinical understanding. Clin Exp Med 16 (2016), 273–293, 10.1007/s10238-015-0367-0.
5. [5] Muro, Y., Sugiura, K., Nakashima, R., Mimori, T., Akiyama, M., Low prevalence of anti-DFS70/LEDGF antibodies in patients with dermatomyositis and other systemic autoimmune rheumatic diseases. J Rheumatol 40 (2013), 92–93, 10.3899/jrheum.121168.
6. [6] Labrador-Horrillo, M., Martínez, M.A., Selva-O'Callaghan, A., Trallero-Araguás, E., Grau-Junyent, J.M., Vilardell-Tarrés, M., et al. Identification of a novel myositis-associated antibody directed against cortactin. Autoimmun Rev 13 (2014), 1008–1012, 10.1016/j.autrev.2014.08.038.